Academe Learn
CBME Curriculum Preview

Page 21 of 21

DR2.1,DR3.1-3,DR4.1 | Papulosquamous & Pigmentary Disorders — PBL Case

CLINICAL SETTING

You are a final-year MBBS student on a 2-week dermatology posting at a district hospital in Tamil Nadu. The outpatient clinic sees a high volume of patients with hypopigmentary disorders, and the attending consultant has asked your small group to work up the following case and present your reasoning at the end of the session. This case is designed to build your differential diagnosis skills for pale patches and to integrate the management of two co-existing dermatological conditions in the same patient.

Trigger 1: First Encounter — The Pale Patches

Mrs Lakshmi, a 34-year-old primary school teacher from a rural district, presents to the dermatology OPD with a 2-year history of progressively enlarging white patches on her face, neck, and dorsum of both hands. She is deeply distressed because her school management has raised concerns about her appearance, suggesting she may have a 'contagious disease.' She has been using a fairness cream on the patches for 8 months with no effect. On examination: - Multiple sharply demarcated, milky-white macules over the perioral area, bilateral cheeks, dorsa of both hands, and the front of both ankles. - The affected areas show complete absence of pigment with a clearly visible sharp margin against the surrounding normal skin. - Wood's lamp: brilliant chalk-white fluorescence in all affected areas, accentuating the margins. - Sensation in the patches: normal light touch and pinprick. - No scaling, no surface change, no atrophy. - Thyroid gland: no palpable enlargement. - Nails: normal. - Family history: her mother had similar patches on her hands.

DISCUSSION POINTS

  • What is your primary diagnosis, and what specific features in this examination support it? Distinguish between depigmentation and hypopigmentation — which is present here, and why does this distinction matter?
  • What is the most important differential diagnosis to exclude in a patient from rural Tamil Nadu with white patches, and which specific examination findings in this case allow you to confidently exclude it? Identify the three key clinical discriminators.
  • What does the positive family history and thyroid examination tell you about the pathogenesis of this patient's condition? What associated autoimmune conditions would you screen for?
  • How would you address Mrs Lakshmi's immediate concern that her condition might be contagious? What counselling would you provide about the nature and prognosis of the condition?
Click to reveal Trigger 2: New Finding — The Itchy Wrist Rash (discuss previous trigger first!)

Trigger 2: New Finding — The Itchy Wrist Rash

While examining Mrs Lakshmi for vitiligo, you notice that she has also been silently scratching both wrists during the consultation. On direct questioning, she mentions 'some itchy bumps on my wrists' for the past 3 months, which she assumed were unrelated. She did not mention it spontaneously because she was focused on the white patches. On examination of the wrists and forearms: - Multiple discrete, flat-topped, polygonal, intensely pruritic papules over the flexor aspect of both wrists and the lower inner forearms. - Colour: violaceous (purple-pink). - Surface: on close inspection with a hand lens, a fine white lace-like network is visible on the surface of several papules. - No scaling, no satellite lesions, no vesicles. - Oral examination: bilateral white streaks on the buccal mucosa, non-removable, asymptomatic. - Koebner test (isomorphic response): a linear arrangement of smaller similar papules along a recent scratch mark on the left forearm.

DISCUSSION POINTS

  • Name and describe the diagnostic surface sign you have identified on the wrist papules. What is its histological basis, and why is it pathognomonic of this condition?
  • Apply the '6 P's' to describe these lesions systematically. How does the distribution (flexor wrists) and the oral mucosal finding help confirm your diagnosis?
  • Both vitiligo and lichen planus show a Koebner (isomorphic) phenomenon. What does the Koebner response in lichen planus tell you about disease activity in this patient, and how does it influence your management timing?
  • How do you counsel Mrs Lakshmi about having two separate skin conditions simultaneously? What is the most likely unifying biological explanation (hint: consider the immune mechanism shared between vitiligo and lichen planus)?
Click to reveal Trigger 3: Management Decisions — Two Conditions, One Patient (discuss previous trigger first!)

Trigger 3: Management Decisions — Two Conditions, One Patient

Your attending consultant asks your group to formulate a combined management plan for Mrs Lakshmi. The following information is now available: - Vitiligo: non-segmental type, affecting approximately 12% BSA, active (new lesions appearing in the last 3 months). - Lichen planus: moderate, bilateral flexor wrists and lower forearms, oral involvement (reticular, asymptomatic), positive Koebner. - Investigations returned: TFTs — TSH 6.8 mIU/L (slightly elevated); FT4 normal. ANA — 1:80 (weakly positive). FBS — normal. - She is not pregnant and is not planning pregnancy in the next year. No significant drug history. The intern suggests: 'Since both conditions are inflammatory, we should give her oral prednisolone — it will treat both at once.' Your consultant asks the group to evaluate this suggestion carefully.

DISCUSSION POINTS

  • Evaluate the intern's suggestion: Is systemic corticosteroid therapy appropriate for lichen planus? For active vitiligo? What are the specific indications for oral dexamethasone minipulse in vitiligo, and how does this differ from a standard prednisolone course?
  • Construct a prioritised management plan for Mrs Lakshmi, addressing both conditions separately. For vitiligo: state first-line treatment for active non-segmental disease and the role of NB-UVB. For lichen planus: choose appropriate first-line therapy for the skin lesions and the asymptomatic oral involvement, justifying your choice.
  • The TSH is mildly elevated. How does subclinical hypothyroidism relate to vitiligo? What would you recommend regarding the thyroid finding and who should manage it?
  • Mrs Lakshmi asks: 'Will my white patches ever come back to normal colour? What are the chances?' How do you frame realistic expectations for repigmentation in active non-segmental vitiligo, including which sites respond best and which respond least?
Click to reveal Trigger 4: Follow-Up and Health-System Reflection (discuss previous trigger first!)

Trigger 4: Follow-Up and Health-System Reflection

Three months later, Mrs Lakshmi returns for follow-up. The lichen planus on her wrists has largely resolved after topical clobetasol proprionate application and a 3-week course of oral prednisolone (prescribed for the lichen planus). The oral lesions remain as faint white streaks. The vitiligo has stabilised — no new lesions for 8 weeks — and she has started NB-UVB phototherapy at the district hospital. She reports that several of her students have similar white patches, and two of them have been sent to her by their parents asking for advice. Her follow-up examination reveals: three new achromic macules over the right shin (appeared in the last 2 weeks).

DISCUSSION POINTS

  • The three new vitiligo macules appeared despite recent stabilisation. What does this tell you about disease activity? Revise your management plan — should oral dexamethasone minipulse be reconsidered at this stage? State the typical minipulse regimen and its rationale.
  • The oral prednisolone that correctly treated Mrs Lakshmi's lichen planus was prescribed at a district hospital by a junior doctor. What safeguard systems and documentation would prevent the same doctor from (appropriately but for the wrong indication) prescribing oral prednisolone to a future psoriasis patient? Reflect on systemic safety in prescribing.
  • Two of Mrs Lakshmi's students have white patches. What rapid clinical assessment would you teach her to perform — and what features in a child's white patch would prompt urgent referral to a dermatologist? (Consider: leprosy prevalence, pityriasis alba, and vitiligo in children.)
  • Reflect on the social and occupational impact of visible skin disease in India. What structural barriers does Mrs Lakshmi face in accessing phototherapy three times a week? Propose one feasible adaptation that district health services could offer.